STOCK TITAN

EDAP TMS (FOCL) AGM approves director slate, capital mandates and bylaw changes

Filing Impact
(High)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

EDAP TMS S.A. held its 2026 Annual General Meeting on June 26, 2026, where shareholders approved multiple governance and capital-related resolutions. A total of 37,484,065 Ordinary Shares, including those represented by American Depositary Shares, were represented and voted.

Shareholders renewed the terms of all nominated directors, ratified the temporary appointment of David Horn, approved related-person agreements, and validated the 2025 statutory and consolidated financial statements and result allocation. They also renewed the statutory auditor and backed executive compensation and annual say‑on‑pay votes.

Extensive delegations were granted to the Board to increase share capital through various issuances, including with or without preferential subscription rights, and in connection with mergers or asset contributions, as well as to grant free shares. Bylaw amendments affecting share capital, the Board of Directors, and shareholders’ meetings were approved, while a capital increase for employees in a company savings plan was not approved.

Positive

  • None.

Negative

  • None.

Insights

Shareholders backed broad capital and governance flexibilities with one notable employee-plan rejection.

The meeting shows strong overall support for EDAP TMS S.A.’s board and governance framework. All directors up for renewal were approved with large majorities, 2025 statutory and consolidated financial statements were validated, and the auditor’s mandate was renewed, signaling continuity in oversight.

Shareholders authorized wide-ranging delegations for the Board to increase share capital via issuances with or without preferential subscription rights, including targeted offerings and transactions linked to mergers, spin-offs, or asset contributions. These tools provide flexibility for future financing or strategic combinations, though actual use would depend on later Board decisions and market conditions.

They also approved free-share grants for employees and officers but rejected a specific capital increase for employee company savings plans, suggesting some limits on dilution mechanisms tied to employee participation. Bylaw amendments touching share capital, the Board, and shareholders’ meetings were adopted, aligning the company’s statutes with the newly approved authorities and governance preferences.

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Governance
The company amended its charter documents, bylaws, or changed its fiscal year.
Item 5.07 Submission of Matters to a Vote of Security Holders Governance
Results of a shareholder vote on proposals at an annual or special meeting.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Shares represented at AGM 37,484,065 Ordinary Shares Ordinary Shares represented and voted at 2026 Annual General Meeting
Vote for Ryan Rhodes renewal 36,821,142 votes for Director term renewal resolution at 2026 Annual General Meeting
Vote for 2025 statutory financials 37,057,443 votes for Approval of statutory financial statements for year ended December 31, 2025
Vote for consolidated financials 37,063,766 votes for Approval of consolidated financial statements for year ended December 31, 2025
Vote for capital increase with rights 35,652,807 votes for Delegation to Board to increase share capital with preferential subscription rights
Vote for capital increase without rights (public offering) 35,109,152 votes for Delegation to Board to increase share capital without preferential rights via public offering
Vote for free-share grants 35,699,794 votes for Authorization to grant existing or newly issued free shares to employees and officers
Vote against employee savings-plan increase 28,912,550 votes against Resolution to increase capital for company savings plan members not approved
preferential subscription rights financial
"to increase the share capital, by issuance of shares or other securities giving access to the Company’s share capital, with preferential subscription rights for shareholders"
Preferential subscription rights are a temporary opportunity given to existing shareholders to buy new shares before those shares are offered to the public, letting them keep their ownership stake instead of being diluted. Think of it like being offered the first chance to buy extra tickets when an event sells more seats; for investors, exercising those rights preserves voting power and value, while selling the rights can raise cash or offset the impact of a company’s fundraising.
non-binding advisory basis regulatory
"The resolution approving, on a non-binding advisory basis, the compensation of the named executive officers of the Company was approved"
A non-binding advisory basis is guidance or a recommendation offered for informational purposes that does not create legal obligations or guarantees; recipients can accept, modify, or ignore it without contractual consequences. Investors should treat it like a weather forecast for planning—useful for forming expectations and assessing risk, but not a firm promise—so they should verify assumptions, seek confirming information, and avoid relying on it as the sole basis for investment decisions.
company savings plan(s) (plan(s) d’épargne d’entreprise) financial
"to increase the Company’s share capital for the benefit of employees who are members of a company savings plan(s) (plan(s) d’épargne d’entreprise)"
merger-absorption financial
"The resolution delegating authority to the Board of Directors to decide on any merger-absorption, spin-off or partial contribution of assets was approved"
free shares financial
"to grant existing and/or newly issued free shares of the Company to all or certain employees and/or all or certain corporate officers"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
false --12-31 0001041934 0001041934 2026-06-26 2026-06-26 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): June 26, 2026

 

EDAP TMS SA

(Exact name of Registrant as specified in its charter)

 

France 000-29374 98-1644844

(State or other jurisdiction of incorporation)

(Commission File No.)

(I.R.S. Employer Identification No.)

 

Parc d’Activites la Poudrette-Lamartine

4/6, rue du Dauphiné

Vaulx-en-Velin, France 69120

(Address of Principal Executive Offices) (Zip Code)

 

Registrant’s telephone number, including area code: (+33) 47-215-3150

 

Not Applicable

(Former name or former address if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

_______________________________

Securities registered pursuant to Section 12(b) of the Act:

 

Title of Each Class Trading Symbol(s) Name of Each Exchange on Which Registered
American Depositary Shares, each representing one Ordinary Share (Ordinary Shares, nominal value €0.13 per share) FOCL NASDAQ Global Market

 

Indicated by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging Growth Company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.    

 

 

 

 

Item 5.03Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

 

At the 2026 Annual General Meeting of Shareholders (the “2026 Annual General Meeting”) of EDAP TMS S.A. (the “Company”) held on June 26, 2026, the Company’s shareholders approved amendments to the bylaws (statuts) of the Company, effective June 26, 2026. The amendments (i) amend Articles 7 and 8 of the bylaws (relating to the share capital), (ii) amend Article 14 of the bylaws (relating to the Board of Directors), (iii) amend Article 22 of the bylaws (relating to the Shareholders’ Meeting), and (iv) effect certain nonmaterial amendments to Articles 9, 20, 21, 26, 30 and 31 of the bylaws, in each case as approved under Resolutions 29 through 32 described in Item 5.07 below.

 

The foregoing description of the amendments to the bylaws is qualified in its entirety by reference to the full text of the amended bylaws, the English translation of which is attached hereto as Exhibit 3.1 and incorporated herein by reference.

 

Item 5.07Submission of Matters to a Vote of Security Holders.

 

On June 26, 2026, the Company held the 2026 Annual General Meeting at its registered office located at Parc d’Activites la Poudrette-Lamartine, 4/6, rue de Dauphiné, 69120 Vaulx-en-Velin, France. A total of 37,484,065 Ordinary Shares (including Ordinary Shares represented by American Depositary Shares) were represented and voted at the 2026 Annual General Meeting. The number of votes cast for and against, and the number of abstentions, with respect to each matter voted upon at the 2026 Annual General Meeting are set forth below.

 

Ordinary Shares underlying American Depositary Shares for which the depositary (the “Depositary”) did not receive timely voting instructions were voted by the Depositary, or by the Depositary’s discretionary proxy, in accordance with the recommendations of the Board of Directors, as described in the proxy statement for the 2026 Annual General Meeting; accordingly, there were no broker non-votes with respect to any matter.

 

1. The resolution renewing the term of office of Ryan Rhodes as director was approved, based upon the following votes:

 

Voted For Voted Against Abstained
36,821,142 476,781 186,142

 

2. The resolution renewing the term of office of Dr. Lance Willsey as director was approved, based upon the following votes:

 

Voted For Voted Against Abstained
36,680,178 617,745 186,142

 

3. The resolution renewing the term of office of Fran Schulz as director was approved, based upon the following votes:

 

Voted For Voted Against Abstained
36,835,613 467,444 181,008

 

4. The resolution renewing the term of office of Josh Levine as director was approved, based upon the following votes:

 

Voted For Voted Against Abstained
37,168,687 134,581 180,797

 

 

 

 

5. The resolution ratifying the temporary appointment of David Horn as director decided by the Board of Directors on February 11, 2026 was approved, based upon the following votes:

 

Voted For Voted Against Abstained
37,179,197 109,071 195,797

 

6. The resolution renewing the term of office of David Horn as firector was approved, based upon the following votes:

 

Voted For Voted Against Abstained
37,170,082 109,116 204,867

 

7. The resolution approving the related-person agreements referred to in Article L. 225-38 of the French Commercial Code was approved, based upon the following votes:

 

Voted For Voted Against Abstained
36,366,419 803,798 313,848

 

8. The resolution approving the statutory financial statements for the fiscal year ended December 31, 2025 was approved, based upon the following votes:

 

Voted For Voted Against Abstained
37,057,443 375,170 51,452

 

9. The resolution approving the consolidated financial statements (US GAAP and IFRS) for the fiscal year ended December 31, 2025 was approved, based upon the following votes:

 

Voted For Voted Against Abstained
37,063,766 385,370 34,929

 

10. The resolution approving the allocation of the results for the fiscal year ended December 31, 2025 was approved, based upon the following votes:

 

Voted For Voted Against Abstained
37,033,713 375,193 75,159

 

11. The resolution renewing the term of office of AGILI3F as statutory auditor was approved, based upon the following votes:

 

Voted For Voted Against Abstained
36,892,459 392,508 199,098

 

 

 

 

12. The resolution approving, on a non-binding advisory basis, the compensation of the named executive officers of the Company was approved, based upon the following votes:

 

Voted For Voted Against Abstained
36,248,209 1,070,150 165,706

 

13. The resolution recommending, on a non-binding advisory basis, that future non-binding advisory votes on the compensation of the named executive officers of the Company be held every year was approved, based upon the following votes:

 

Voted For Voted Against Abstained
36,249,837 1,071,631 162,597

 

14. The resolution recommending, on a non-binding advisory basis, that future non-binding advisory votes on the compensation of the named executive officers of the Company be held every two years was not approved, based upon the following votes:

 

Voted For Voted Against Abstained
8,200,822 29,093,425 189,818

 

15. The resolution recommending, on a non-binding advisory basis, that future non-binding advisory votes on the compensation of the named executive officers of the Company be held every three years was not approved, based upon the following votes:

 

Voted For Voted Against Abstained
8,323,552 28,970,695 189,818

 

16. The resolution delegating authority to the Board of Directors to increase the share capital, by issuance of shares or other securities giving access to the Company’s share capital, with preferential subscription rights for shareholders was approved, based upon the following votes:

 

Voted For Voted Against Abstained
35,652,807 1,795,765 35,493

 

17. The resolution delegating authority to the Board of Directors to increase the share capital, by issuance of shares or other securities giving access to the Company’s share capital, with cancellation of shareholders’ preferential subscription rights, by means of a public offering (excluding offerings referred to in paragraph 1 of Article L. 411-2 of the French Monetary and Financial Code) was approved, based upon the following votes:

 

Voted For Voted Against Abstained
35,109,152 2,328,650 46,263

 

 

 

 

18. The resolution delegating authority to the Board of Directors to increase the share capital, by issuance of shares or other securities giving access to the Company’s share capital, with cancellation of shareholders’ preferential subscription rights, through an offer referred to in paragraph 1 of Article L. 411-2 of the French Monetary and Financial Code was approved, based upon the following votes:

 

Voted For Voted Against Abstained
35,106,547 2,326,511 51,007

 

19. The resolution delegating authority to the Board of Directors to increase the share capital, by issuance of shares or other securities giving access to the Company’s share capital, with cancellation of shareholders’ preferential subscription rights, in favor of a first category of persons who meet certain specified characteristics was approved, based upon the following votes:

 

Voted For Voted Against Abstained
35,091,840 2,345,437 46,788

 

20. The resolution delegating authority to the Board of Directors to increase the share capital, by issuance of shares or other securities giving access to the Company’s share capital, with cancellation of shareholders’ preferential subscription rights, in favor of a second category of persons who meet certain specified characteristics was approved, based upon the following votes:

 

Voted For Voted Against Abstained
35,302,845 2,076,762 104,458

 

21. The resolution delegating authority to the Board of Directors to increase the share capital, by issuance of shares or other securities giving access to the Company’s share capital, with cancellation of shareholders’ preferential subscription rights, in favor of a third category of persons who meet certain specified characteristics was approved, based upon the following votes:

 

Voted For Voted Against Abstained
35,233,170 2,146,437 104,458

 

22. The resolution delegating authority to the Board of Directors to increase the number of securities to be issued in the event of a capital increase, with or without preferential subscription rights, decided pursuant to the foregoing delegations was approved, based upon the following votes:

 

Voted For Voted Against Abstained
35,386,773 1,995,094 102,198

 

23. The resolution delegating authority to the Board of Directors to decide on any merger-absorption, spin-off or partial contribution of assets was approved, based upon the following votes:

 

Voted For Voted Against Abstained
36,397,257 986,288 100,520

 

24. The resolution delegating authority to the Board of Directors to issue ordinary shares giving, as the case may be, access to ordinary shares or to the allocation of debt securities (of the Company or of a group company), and/or securities giving access to ordinary shares (of the Company or of a group company), in the context of a merger, spin-off or partial contribution of assets decided by the Board of Directors pursuant to Resolution 23 was approved, based upon the following votes:

 

Voted For Voted Against Abstained
35,751,819 1,652,962 79,284

 

 

 

 

25. The resolution determining the overall maximum amount applicable to the financial delegations granted to the Board of Directors to increase the share capital pursuant to Resolution 16 through Resolution 24 was approved, based upon the following votes:

 

Voted For Voted Against Abstained
35,501,019 1,902,622 80,424

 

26. The resolution delegating authority to the Board of Directors to increase the share capital, by issuance of shares or other securities giving access to the Company’s share capital, with cancellation of shareholders’ preferential subscription rights, in favor of the European Investment Bank (the “EIB”) or any entity succeeding the EIB in connection with any financing contract was approved, based upon the following votes:

 

Voted For Voted Against Abstained
35,690,312 1,721,195 72,558

 

27. The resolution authorizing the Board of Directors to grant existing and/or newly issued free shares of the Company to all or certain employees and/or all or certain corporate officers of the Company or companies in the group, in accordance with the provisions of Articles L. 225-197-1 et seq. of the French Commercial Code, with automatic waiver of the shareholders’ preferential subscription rights for the new shares that may be issued was approved, based upon the following votes:

 

Voted For Voted Against Abstained
35,699,794 1,653,657 130,614

 

28. The resolution delegating authority to the Board of Directors to increase the Company’s share capital for the benefit of employees who are members of a company savings plan(s) (plan(s) d’épargne d’entreprise) implemented pursuant to Articles L. 3332-1 et seq. of the French Labor Code was not approved, based upon the following votes:

 

Voted For Voted Against Abstained
8,440,182 28,912,550 131,333

 

29. The resolution approving amendments to Articles 7 and 8 of the bylaws of the Company (articles related to share capital) was approved, based upon the following votes:

 

Voted For Voted Against Abstained
36,457,465 828,770 197,830

 

30. The resolution approving amendments to Article 14 of the bylaws of the Company (article related to the Board of Directors) was approved, based upon the following votes:

 

Voted For Voted Against Abstained
36,487,556 799,770 196,739

 

 

 

 

31. The resolution approving amendments to Article 22 of the bylaws of the Company (article related to the Shareholders’ Meeting) was approved, based upon the following votes:

 

Voted For Voted Against Abstained
36,522,806 740,484 220,775

 

32. The resolution approving nonmaterial amendments to the bylaws of the Company was approved, based upon the following votes:

 

Voted For Voted Against Abstained
36,810,767 552,014 121,284

 

Item 9.01Financial Statements and Exhibits.

 

(d) Exhibits

 

Exhibit No.   Description
   
3.1   Update to the bylaws (statuts) of EDAP TMS S.A. (English translation)
104   Cover Page Interactive Data File-the cover page XBRL tags are embedded within the Inline XBRL document

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  EDAP TMS S.A.
     
Date: June 26, 2026 By: /s/ Sanket Shah
    Sanket Shah
   

General Counsel and Corporate Secretary

 

 

 

 

 

 

 

 

 

 

FAQ

What did EDAP TMS (FOCL) shareholders approve at the 2026 Annual General Meeting?

Shareholders approved all director renewals, related-person agreements, 2025 statutory and consolidated financial statements, result allocation, auditor renewal, extensive capital-increase delegations to the Board, free-share grants, and several bylaw amendments relating to share capital, the Board, and shareholders’ meetings.

How many EDAP TMS (FOCL) shares were represented at the 2026 Annual General Meeting?

A total of 37,484,065 Ordinary Shares, including Ordinary Shares represented by American Depositary Shares, were represented and voted. This reflects strong participation by holders and provided the quorum needed to decide all 32 resolutions presented at the meeting.

Were EDAP TMS (FOCL) directors re-elected at the 2026 meeting?

Yes. All director-related resolutions were approved, including renewals for Ryan Rhodes, Dr. Lance Willsey, Fran Schulz, Josh Levine, and David Horn, plus ratification of Horn’s temporary appointment. Each resolution received substantial “for” votes relative to votes against and abstentions.

Did EDAP TMS (FOCL) shareholders approve capital increase authorizations for the Board?

Yes. Shareholders granted the Board multiple delegations to increase share capital by issuing shares or other securities, both with preferential subscription rights and with rights canceled, including for public offerings, targeted investors, and transactions linked to mergers or asset contributions.

How did EDAP TMS (FOCL) shareholders vote on executive compensation at the 2026 meeting?

Shareholders approved, on a non-binding advisory basis, the compensation of named executive officers and recommended holding say‑on‑pay votes every year. The annual frequency resolution received far more support than alternatives proposing votes every two or three years.

Which EDAP TMS (FOCL) resolutions were not approved at the 2026 Annual General Meeting?

Two resolution types failed: holding say‑on‑pay votes every two years, and every three years, both losing to the annual frequency option. Additionally, a resolution to increase share capital for employees participating in company savings plans was not approved by shareholders.

What bylaw changes did EDAP TMS (FOCL) shareholders approve in 2026?

Shareholders approved amendments to Articles 7 and 8 on share capital, Article 14 on the Board of Directors, Article 22 on shareholders’ meetings, and certain nonmaterial updates to other articles. These changes are reflected in the updated bylaws attached as an exhibit to the report.

Filing Exhibits & Attachments

4 documents